Blood Bags Market by Type, Material, Usability, End-Use

List of Tables

[193 Pages Report] The Blood Bags Market size was estimated at USD 526.17 million in 2023 and expected to reach USD 561.67 million in 2024, at a CAGR 6.83% to reach USD 836.09 million by 2030.

Blood bags are a vital component of the medical industry, as they are used to store and transport blood and blood components. Blood bags help to ensure the safety of both the patient receiving the donated blood and the donor providing it. They also help to reduce contamination, minimize wastage, and promote efficient use of resources. By keeping donated blood in a controlled environment, blood bags can help prolong its shelf life and maintain optimal quality. The main trends driving this growth include increasing demand for blood transfusions, rising prevalence of infectious diseases, technological advancements in blood storage and transportation, and increasing public health awareness about the importance of donating/storing blood for emergencies. However, limited supportive healthcare infrastructure in some countries and potential risks related to the material of blood bags can create hurdles for market growth. Advancements in blood bag manufacturing and materials create opportunities for a wider range of blood products and allow providers to offer better-quality products to their customers.

KEY MARKET STATISTICS
Base Year [2023]	USD 526.17 million
Estimated Year [2024]	USD 561.67 million
Forecast Year [2030]	USD 836.09 million
CAGR (%)	6.83%

Type: Increasing demand for single blood bags as they are cost-effective and straightforward compared to multi-component alternatives

Single blood bags are designed to store and transport a single blood or blood component unit. They usually consist of a primary bag for collecting the blood and a secondary bag for preserving the integrity of the blood during storage. A double blood bag is designed to collect and separate whole blood into two different blood components; plasma and red cells. Triple blood features an additional compartment for platelet storage and is utilized when blood components, such as red blood cells, plasma, and platelets, must be collected and preserved separately. Quadruple blood bags are the most complex type for collecting and storing multiple blood components.

End-Use: Significant use of blood bags by the blood blanks

Blood banks and hospitals use blood bags to provide aseptic conditions for separating blood components. Blood banks rely on different types of blood bags to store and preserve donated blood and its components. They use single, double, triple, and quadruple blood bags to collect whole blood and separate it into its features, such as red blood cells, plasma, platelets, and cryoprecipitate. Hospitals are another significant end-user of blood bags. They rely on blood bags to receive and administer blood transfusions to patients during surgeries, treatments, and emergencies.

Usability: Growing popularity of transfer bags for securely transport blood samples

Blood collection bags are specialized medical devices designed for collecting and preserving blood during donation. These bags are used in blood banks, hospitals, and other healthcare settings to collect whole blood or specific blood components from donors. Transfer bags are specifically designed to securely transport blood samples from one laboratory or facility to another. These bags feature special pockets for multiple samples and additional space for paperwork, documentation, and other accessories needed for transportation.

Material: Rising adoption of polyvinyl chloride (PVC) due to its high durability and lightweight properties

Polyvinyl chloride (PVC) is a commonly used blood bag material. It is highly durable, lightweight, and resistant to punctures and tears. It allows for easy visualization of the blood and facilitates proper monitoring during collection, storage, and transfusion. Polyolefins are another type of material used for blood bags. They are lightweight, non-toxic, and highly resistant to temperature change. Polyolefins also have a superior oxygen permeability compared to PVC, which makes them an ideal choice for long-term storage of blood products. Polyethylene terephthalate (PET) has transparency, flexibility, strength, and chemical resistance. This material offers excellent barrier properties against water vapor and oxygen while maintaining good heat resistance and is used for collecting and storing platelets and plasma. Moreover, polyurethane blood bags are made from polyurethane, a versatile polymer known for its flexibility, durability, and biocompatibility. Ethylene-vinyl acetate (EVA) blood bags are designed to reduce microbial growth and provide longer shelf life for stored blood products.

Regional Insights

The rising road crashes, increase in the number of surgeries, and labeling standards for blood bags are accelerating the need and use of blood bags in the Americas. The rising number of surgeries requiring blood transfusions, government initiatives to encourage blood donation, and the significant presence of blood bag manufacturers have increased the availability and usage of blood bags in the APAC region. Europe, the Middle East, and Africa market represent a developing landscape for the blood bags market owing to the rising number of surgeries, favorable government initiatives for blood donations, and emerging product development activities in the region. Additionally, the ongoing advancements and research in the material and design of blood bags are expected to facilitate the use of blood bags worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Bags Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Bags Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Bags Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Advin Health Care, Alvedia, B L Lifesciences Private Limited, Demophorius Limited, Fresenius SE & Co. KGaA, Grifols, S.A, HAEMONETICS CORPORATION, HLL Lifecare Limited, HANSLER MEDICAL GMBH, Inovet, JMS Co., Ltd., KIEFEL GmbH, Lmb Technologie GmbH, Maco Pharma SAS, Mitra Industries Pvt. Ltd., Narang Medical Limited, Neomedic, Olidef Medical, Poly Medicure Limited, Qingdao Sinoland International Trade Co., Ltd., RENOLIT SE, SB-Kawasumi Laboratories, Inc., Shandong Weigao Group Medical Polymer Co.,Ltd., Suru International Pvt. Ltd., Suzhou Sinomed Co., Ltd., Terumo Corporation, The Metrix Company, TROGE MEDICAL GmbH, and Xindray Medical International Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Blood Bags Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Double
- Quadruple
- Single
- Triple

Material
- Polyethylene Terephthalate
- Polyolefins
- Polyvinyl Chloride

Usability
- Collection Bag
- Transfer Bag

End-Use
- Blood Banks
- Hospital

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Bags Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Bags Market?

3. What are the technology trends and regulatory frameworks in the Blood Bags Market?

4. What is the market share of the leading vendors in the Blood Bags Market?

5. Which modes and strategic moves are suitable for entering the Blood Bags Market?

Product Code: MRR-437D45958098

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing number of road accidents and trauma cases creating need for blood
  - 5.1.1.2. Government initiatives encouraging blood donations and rising need for safe blood storage and transportation services
- 5.1.2. Restraints
  - 5.1.2.1. Harmful waste produced due to usage of blood bags along with adverse impact of PVC material
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in the blood bags field
  - 5.1.3.2. Increasing number of blood banks globally
- 5.1.4. Challenges
  - 5.1.4.1. Managing the blood safety during transfusion and complex requirement of maintaining precise blood bag temperature
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing demand for single blood bags as they are cost-effective and straightforward compared to multi-component alternatives
- 5.2.2. End-Use: Significant use of blood bags by the blood blanks
- 5.2.3. Usability: Growing popularity of transfer bags for securely transport blood samples
- 5.2.4. Material: Rising adoption of polyvinyl chloride (PVC) due to its high durability and lightweight properties
5.3. Market Trend Analysis
- 5.3.1. Well-established regulatory standards for blood bags in the Americas
- 5.3.2. Surge in blood donation activities and significant presence of blood bag manufacturers in the APAC region
- 5.3.3. Ongoing product developments and encouraging blood donation initiatives expand the market growth in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis

6. Blood Bags Market, by Type

6.1. Introduction
6.2. Double
6.3. Quadruple
6.4. Single
6.5. Triple

7. Blood Bags Market, by Material

7.1. Introduction
7.2. Polyethylene Terephthalate
7.3. Polyolefins
7.4. Polyvinyl Chloride

8. Blood Bags Market, by Usability

8.1. Introduction
8.2. Collection Bag
8.3. Transfer Bag

9. Blood Bags Market, by End-Use

9.1. Introduction
9.2. Blood Banks
9.3. Hospital

10. Americas Blood Bags Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Blood Bags Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Blood Bags Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. BetaLife to Showcase Its AI Powered Health Tech Solution for Advancing Health Equity at GITEX AFRICA 2023 The Largest Tech Event
- 13.3.2. ICMR Runs Trial of Blood Bag Delivery Under iDrone Initiative
- 13.3.3. Trial Run of Blood Bag Delivery under the iDrone Initiative of ICMR successfully conducted
- 13.3.4. DBT Institute Develops Novel Bags To Increase Shelf Life Of Blood
- 13.3.5. Maco Medlab: Joint-Venture of 2 blood transfusion players
- 13.3.6. For Start-Ups, Industry, Kerala Doubles Financial Assistance to INR 10 Million
- 13.3.7. NBSC Calls for Investment in Blood Bank
- 13.3.8. U.S. Gov awards USD 10.6 Million Freeze-Dried Plasma Contract to Terumo

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio